People with a group 1 cancer typically have an early stage, potentially curable cancer and a prognosis of a decade or more. Most people survive in the long term, often in relatively good health (and many live for more than a decade) |
People with a group 2 cancer often have treatable but not curable disease, typically having multiple lines of treatment. Most people experience cancer as a complex ongoing disease similar to a long-term condition |
People with a group 3 cancer typically develop advanced disease and often have <12 months prognosis. Most people have relatively poor health |
Often face long-term consequences of their cancer and its treatment. May face recurrence even years after primary treatment |
Often have a complex pathway, with multiple decision points, commonly experience relapse or recurrence |
Often face short survival times, mostly incurable disease and complex, time-sensitive decisions needed |
Focus on recovery and long-term quality of life:
Reduce unnecessary overtreatment, focus on its impact on recovery and late effects38
Management of co-morbidities
Recovery package, including stratified pathways and self-care with support and open access39
Periodic monitoring of heath, eg, for cardio function and fatigue25
|
Care must preserve quality of life through balance of:
Acute intervention
Chronic illness management27
Palliative care principals40
Shared care between patient and clinician39
Acknowledgement that cancer is likely to be life-limiting
Recognition when move to dying phase
|
Balance of anticancer treatment and palliative care to maintain quality of life. Focus care on:
|